Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ZBRA
Valuation Weak
28%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -5.36 0.99 1.05
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -39.79 10.15 16.86
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 4.34 61.67 59.10
Cash -5.27 3.17 3.35
Capex 64.12 -0.27 -0.76
Free Cash Flow 8.78 2.16 1.99
Revenue 16.42 22.85 19.62
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 9.31 0.46 0.42
Operating Margin 59.45 0.14 0.09
ROA 580.85 0.02 < 0.005
ROE 548.08 0.04 < 0.005
ROIC -82.30 0.03 0.15
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ZBRA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ZBRA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ZBRA is permitted for members.